"It's Superspeciality hospital with excellent skill and reputation in Critical care Department Critical Care Gastroenterology & Gastro Surgery Neuro & Spine Surgery Neurology Cardiology Urology Pulmonologist Ortho & Trauma Joint Replacement Oncology Oncosurgery Nephrology Laparoscopic & General Surgery High Risk Gynecology & Obstetrics Internal Medicine"

During the past decade, Shree Giriraj Multispeciality Hospital conducted 21 clinical trials. In the 10-year time frame, 21 clinical trials started and 10 clinical trials were completed, i.e. on average, 47.6% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 10 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Shree Giriraj Multispeciality Hospital" #1 sponsor was "Eli Lilly and Company" with 6 trials, followed by "Galapagos NV" with 3 trials sponsored, "Janssen Research & Development, LLC" with 3 trials sponsored, "Adocia" with 1 trials sponsored and "Boehringer Ingelheim" with 1 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Shree Giriraj Multispeciality Hospital" #1 collaborator was "Gilead Sciences" with 3 trials as a collaborator, "Incyte Corporation" with 2 trials as a collaborator, "Galapagos NV" with 1 trials as a collaborator, "Indian Society of Critical Care Medicine" with 1 trials as a collaborator and "Nektar Therapeutics" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Shree Giriraj Multispeciality Hospital" are "Ulcerative Colitis" (5 trials), "Crohn's Disease" (3 trials), "Colitis, Ulcerative" (2 trials), "Influenza A" (2 trials) and "Systemic Lupus Erythematosus" (2 trials). Many other conditions were trialed in "Shree Giriraj Multispeciality Hospital" in a lesser frequency.

Most popular intervention types in "Shree Giriraj Multispeciality Hospital" are "Drug" (18 trials), "Other" (6 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "Filgotinib" (4 trials), "Baricitinib" (2 trials), "Mirikizumab" (2 trials) and "Pimodivir 600 mg" (2 trials). Other intervention names were less common.

The vast majority of trials in "Shree Giriraj Multispeciality Hospital" are 21 trials for "All" genders.

Currently, there are NaN active trials in "Shree Giriraj Multispeciality Hospital". undefined are not yet recruiting, 2 are recruiting, 5 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 9 completed trials in Shree Giriraj Multispeciality Hospital, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Shree Giriraj Multispeciality Hospital, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".